The Screen’s Quiet Toll, Israel’s Quiet Cure
The web already regulates flashing light to protect one set of brains. It is time we thought about the rest — and Israel is quietly showing how.
A colleague wrote to me this week with an unusual request. Could a meeting be moved from one video platform to another, because long sessions on certain software left her with crippling migraines. It would have been easy to read this as fussiness, the sort of small accommodation that busy people wave away. It is not. It is an early signal of something the digital economy has not yet been honest with itself about.
We have built a world in which hundreds of millions of people now spend the larger part of their working day staring into conferencing software. These products were engineered for features, for integration, for market share. They were not engineered for the brain. Brightness, on screen clutter, flickering motion, the constant flash of notifications: every platform imposes a different visual load, and for a brain prone to migraine that load is not neutral. The migraine brain is unusually reactive to flicker, to high luminance and to busy motion, which is precisely what an afternoon of video calls delivers in abundance.
What is striking is that we already accept the principle at stake. The web has a rule, observed by every serious designer, that content must not flash more than three times in a single second, because such flashing can trigger seizures in people with photosensitive epilepsy. We drew that line years ago. We treat it as a matter of safety, not preference. Yet for migraine, a condition that afflicts a vastly larger population, we have drawn no comparable line at all. The flicker we regulate for one neurological condition we ignore for another.
The numbers are not small. Migraine affects more than a billion people worldwide. It is among the most disabling conditions in medicine, and it falls most heavily on women in the prime of their working lives. Its cost is paid quietly, in cancelled meetings, darkened rooms and productivity that never appears in any ledger. A condition this widespread ought to shape how we design the tools that everyone now uses for hours a day. Instead it is treated as a private misfortune to be managed by the sufferer alone.
This is where Israel enters the story, and not for the reasons one might expect. While much of the technology industry has quietly worsened the problem, a small Israeli company has spent the better part of a decade engineering the remedy. Theranica, based in Netanya, developed a drug free wearable called Nerivio. Worn on the upper arm and controlled by a smartphone, it uses electrical neuromodulation to recruit the brain’s own pain dampening machinery. It earned American regulatory clearance, was later extended to children as young as eight, and is now recommended by the American Headache Society. A condition that the screen economy keeps aggravating is being met, treatment by treatment, from a laboratory near Tel Aviv.
Nor is Theranica alone, and the pattern matters more than the company. The same country produced OrCam, founded in Jerusalem by the founders of Mobileye, whose finger sized device clips to a pair of glasses and reads printed text and screens aloud for people who are blind, partially sighted or dyslexic. A different condition, a different piece of hardware, but the same underlying instinct: to treat the gap between a human nervous system and the information it is asked to process as a problem worth engineering away, rather than a limitation the sufferer must simply endure. Israel has spent years building real capability at exactly that intersection of neuroscience, vision and machine intelligence, and it has learned to treat accessibility as engineering rather than charity.
That is what makes the next step worth proposing. If a country can build devices that read the world aloud to the blind and quiet the pain of the migraine sufferer, it is also well placed to help define what considerate design looks like at the source: interfaces tested for visual load before they ship, default settings that shield the sensitive rather than punish them, accessibility understood to include the brain and not merely the eye and the ear. I am not claiming Israel does any of this yet. I am suggesting it is among the few places with both the technical expertise and the hard won credibility to lead it. Such a standard would be an export more valuable than any single gadget, because it would shape the behaviour of an entire industry rather than treat one patient at a time.
None of this requires a grand program or a new bureaucracy. It requires recognizing that design is a health question, and that a country already trusted with the nervous system’s harder problems has standing to help define how the rest of us avoid provoking them. Israel is forever asked to justify itself on the world stage. Here is a quieter form of legitimacy, the kind earned by solving a problem that touches a billion people regardless of their politics, their borders or their opinion of the country that helped them.
My colleague will get her preferred platform, and her afternoon will be the better for it. But her request deserves more than a polite accommodation. It is a small reading of a large debt, the unpaid cost of a screen based world assembled without much thought for the brains behind the screens. The country that built the wearable on her arm is also the one best placed to help write the rules that might, one day, make the wearable less necessary. That is worth a good deal more than a meeting link.
